HQL
abrdn Life Sciences Investors
3월 13일 4:00 PM ET (한국 3/14 05:00)
$16.37
-0.25 ▼ -1.50%
🌙 3월 13일 7:56 PM ET (한국 3/14 08:56)
$16.10
-0.27 ▼ -1.65%
| Index | - | P/E | 5.87 | EPS (ttm) | 2.79 | Insider Own | - | Shs Outstand | 0.03B | Perf Week | 3.15% |
| Market Cap | 0.49B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.03B | Perf Month | -3.42% |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | 27.82% | Short Float | 0.06% | Perf Quarter | -5.16% |
| Income | - | P/S | 250.6 | EPS this Y | - | Inst Trans | - | Short Ratio | 0.14 | Perf Half Y | 14.72% |
| Sales | 0.00B | P/B | 0.94 | EPS next 5Y | - | ROA | - | Short Interest | 0.02M | Perf YTD | -2.44% |
| Book/sh | 17.35 | P/C | - | EPS past 3/5Y | - | ROE | - | 52W High | -8.03% ($17.80) | Perf Year | 26.12% |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 55.16% ($10.55) | Perf 3Y | 21.78% |
| Dividend Est. | $1.91 (11.67%) | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 2.34% 1.89% | Perf 5Y | -17.17% |
| Dividend TTM | 1.91 | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.36 | Perf 10Y | -4.91% |
| Dividend Ex-Date | 2026/2/20 | Quick Ratio | - | EPS Q/Q | 279.1% | Profit Margin | - | RSI (14) | 45 | Recom | - |
| Dividend Gr. 3/5Y | 11.05% 3.9% | Current Ratio | - | Sales Q/Q | -69.9% | SMA20 | -1.71% ($16.65) | Beta | 0.74 | Target Price | - |
| Payout | 60.89% | Debt/Eq | - | Earnings | - | SMA50 | -2.61% ($16.81) | Rel Volume | 0.35 | Prev Close | $16.62 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | 6.77% ($15.33) | Avg Volume(3M) | 0.13M | Price | $16.37 |
| IPO | 1992/5/1 | Option/Short | No/Yes | Trades | 232 | Volume | 45,778 | Change | -1.5% |
뉴스 로딩 중...